1
|
Wéry J, Beckers I, De Vos DE. Isopropenyl phosphate as an atom efficient reagent for phosphorylation of alcohols with catalytic base. RSC Adv 2023; 13:14350-14354. [PMID: 37180006 PMCID: PMC10170494 DOI: 10.1039/d3ra02293e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Accepted: 04/19/2023] [Indexed: 05/15/2023] Open
Abstract
The atom efficient transesterification of phosphate esters with catalytic base was investigated using an isopropenyl leaving group, generating acetone as the only by-product. The reaction proceeds in good yields at room temperature, with excellent chemoselectivity towards primary alcohols. Mechanistic insights were obtained by obtaining kinetic data using in operando NMR-spectroscopy.
Collapse
Affiliation(s)
- Jens Wéry
- cMACS, KU Leuven Celestijnenlaan 200F Leuven 3001 Belgium
| | - Igor Beckers
- cMACS, KU Leuven Celestijnenlaan 200F Leuven 3001 Belgium
| | - Dirk E De Vos
- cMACS, KU Leuven Celestijnenlaan 200F Leuven 3001 Belgium
| |
Collapse
|
2
|
Formica M, Rogova T, Shi H, Sahara N, Ferko B, Farley AJM, Christensen KE, Duarte F, Yamazaki K, Dixon DJ. Catalytic enantioselective nucleophilic desymmetrization of phosphonate esters. Nat Chem 2023; 15:714-721. [PMID: 37127757 PMCID: PMC10159838 DOI: 10.1038/s41557-023-01165-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Accepted: 02/20/2023] [Indexed: 05/03/2023]
Abstract
Molecules that contain a stereogenic phosphorus atom are crucial to medicine, agrochemistry and catalysis. While methods are available for the selective construction of various chiral organophosphorus compounds, catalytic enantioselective approaches for their synthesis are far less common. Given the vastness of possible substituent combinations around a phosphorus atom, protocols for their preparation should also be divergent, providing facile access not only to one but to many classes of phosphorus compounds. Here we introduce a catalytic and enantioselective strategy for the preparation of an enantioenriched phosphorus(V) centre that can be diversified enantiospecifically to a wide range of biologically relevant phosphorus(V) compounds. The process, which involves an enantioselective nucleophilic substitution catalysed by a superbasic bifunctional iminophosphorane catalyst, can accommodate a wide range of carbon substituents at phosphorus. The resulting stable, yet versatile, synthetic intermediates can be combined with a multitude of medicinally relevant O-, N- and S-based nucleophiles.
Collapse
Affiliation(s)
- Michele Formica
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Tatiana Rogova
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Heyao Shi
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Naoto Sahara
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
- Graduate School of Engineering, Nagoya University, Nagoya, Japan
| | - Branislav Ferko
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Alistair J M Farley
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Kirsten E Christensen
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Fernanda Duarte
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK
| | - Ken Yamazaki
- Division of Applied Chemistry, Okayama University, Okayama, Japan.
| | - Darren J Dixon
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.
| |
Collapse
|
3
|
Chandra G, Singh DV, Mahato GK, Patel S. Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs. CHEMICKE ZVESTI 2023; 77:1-22. [PMID: 37362786 PMCID: PMC10099028 DOI: 10.1007/s11696-023-02804-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Accepted: 03/29/2023] [Indexed: 06/28/2023]
Abstract
During the last twenty years, organic fluorination chemistry established itself as an important tool to get a biologically active compound. This belief can be supported by the fact that every year, we are getting fluorinated drugs in the market in extremely significant numbers. Last year, also ten fluorinated drugs have been approved by FDA and during the COVID-19 pandemic, fluorinated drugs played a very crucial role to control the disease and saved many lives. In this review, we surveyed all ten fluorinated drugs approved by FDA in 2021 and all fluorinated drugs which were directly-indirectly used during the COVID-19 period, and emphasis has been given particularly to their synthesis, medicinal chemistry, and development process. Out of ten approved drugs, one drug pylarify, a radioactive diagnostic agent for cancer was approved for use in positron emission tomography imaging. Also, very briefly outlined the significance of fluorinated drugs through their physical, and chemical properties and their effect on drug development. Graphical abstract
Collapse
Affiliation(s)
- Girish Chandra
- Department of Chemistry, School of Physical and Chemical Sciences, Central University of South Bihar, SH-7, Gaya Panchanpur Road, Gaya, Bihar 824236 India
| | - Durg Vijay Singh
- Department of Bioinformatics, School of Earth Biological and Environmental Sciences, Central University of South Bihar, SH-7, Gaya Panchanpur Road, Gaya, Bihar 824236 India
| | - Gopal Kumar Mahato
- Department of Chemistry, School of Physical and Chemical Sciences, Central University of South Bihar, SH-7, Gaya Panchanpur Road, Gaya, Bihar 824236 India
| | - Samridhi Patel
- Department of Chemistry, School of Physical and Chemical Sciences, Central University of South Bihar, SH-7, Gaya Panchanpur Road, Gaya, Bihar 824236 India
| |
Collapse
|
4
|
Roy B, Navarro V, Peyrottes S. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications. Curr Med Chem 2023; 30:1256-1303. [PMID: 36093825 DOI: 10.2174/0929867329666220909122820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 07/21/2022] [Accepted: 08/02/2022] [Indexed: 11/22/2022]
Abstract
Nucleoside analogues are widely used as anti-infectious and antitumoral agents. However, their clinical use may face limitations associated with their physicochemical properties, pharmacokinetic parameters, and/or their peculiar mechanisms of action. Indeed, once inside the cells, nucleoside analogues require to be metabolized into their corresponding (poly-)phosphorylated derivatives, mediated by cellular and/or viral kinases, in order to interfere with nucleic acid biosynthesis. Within this activation process, the first-phosphorylation step is often the limiting one and to overcome this limitation, numerous prodrug approaches have been proposed. Herein, we will focus on recent literature data (from 2015 and onwards) related to new prodrug strategies, the development of original synthetic approaches and novel applications of nucleotide prodrugs (namely pronucleotides) leading to the intracellular delivery of 5'-monophosphate nucleoside analogues.
Collapse
Affiliation(s)
- Béatrice Roy
- Team Nucleosides & Phosphorylated Effectors, Institute for Biomolecules Max Mousseron (IBMM), University of Montpellier, Route de Mende, 34293 Montpellier, France
| | - Valentin Navarro
- Team Nucleosides & Phosphorylated Effectors, Institute for Biomolecules Max Mousseron (IBMM), University of Montpellier, Route de Mende, 34293 Montpellier, France
| | - Suzanne Peyrottes
- Team Nucleosides & Phosphorylated Effectors, Institute for Biomolecules Max Mousseron (IBMM), University of Montpellier, Route de Mende, 34293 Montpellier, France
| |
Collapse
|
5
|
Maligres PE, Peng F, Calabria R, Campeau LC, Chen W, Dormer PG, Green M, He CQ, Hyde AM, Klapars A, Larsen MU, Limanto J, Liu G, Liu Y, Moment A, Nowak T, Ruck RT, Shevlin M, Song ZJ, Tan L, Tong W, Waldman JH, Ye H, Zhao R, Zhou G, Zompa MA, Zultanski SL. Manufacturing Process Development for Uprifosbuvir (MK-3682): A Green and Sustainable Process for Preparing Penultimate 2′-Deoxy-α-2′-Chloro-β-2′-Methyluridine. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Peter E. Maligres
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Feng Peng
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Ralph Calabria
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Louis-Charles Campeau
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Wenyong Chen
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Peter G. Dormer
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Meredith Green
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Cyndi Qixin He
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Alan M. Hyde
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Artis Klapars
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Mona Utne Larsen
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - John Limanto
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Guiquan Liu
- Shanghai SynTheAll Pharmaceutical Co. Ltd., 9 Yuegong Road, Jinshan District, Shanghai 201507, China
| | - Yizhou Liu
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Aaron Moment
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Timothy Nowak
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Rebecca T. Ruck
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Michael Shevlin
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Zhiguo Jake Song
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Lushi Tan
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Weidong Tong
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Jacob H. Waldman
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Honglin Ye
- Shanghai SynTheAll Pharmaceutical Co. Ltd., 9 Yuegong Road, Jinshan District, Shanghai 201507, China
| | - Ralph Zhao
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - George Zhou
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Michael A. Zompa
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Susan L. Zultanski
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| |
Collapse
|
6
|
Ying H, Yao J, Wu F, Zhao Y, Ni F. A mild and concise synthesis of aryloxy phosphoramidate prodrug of alcohols via transesterification reaction. RSC Adv 2022; 12:13111-13115. [PMID: 35497010 PMCID: PMC9052952 DOI: 10.1039/d2ra01995g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 04/19/2022] [Indexed: 11/21/2022] Open
Abstract
A synthesis of aryloxy phosphoramidate prodrug of alcohols enabled by a transesterification strategy is described here. This reaction operates under mild conditions and thus has excellent functional group tolerance. This method provides an efficient and practical solution to the rapid construction of the aryloxy phosphoramidate prodrugs library for potential SAR studies. A synthesis of aryloxy phosphoramidate prodrug of alcohols enabled by a transesterification strategy is described here.![]()
Collapse
Affiliation(s)
- Hanglu Ying
- Institute of Drug Discovery Technology, Ningbo University Ningbo Zhejiang 315211 P. R. China .,Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University Ningbo Zhejiang 315211 P. R. China
| | - Jie Yao
- Institute of Drug Discovery Technology, Ningbo University Ningbo Zhejiang 315211 P. R. China .,Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University Ningbo Zhejiang 315211 P. R. China
| | - Fan Wu
- Institute of Drug Discovery Technology, Ningbo University Ningbo Zhejiang 315211 P. R. China .,Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University Ningbo Zhejiang 315211 P. R. China
| | - Yufen Zhao
- Institute of Drug Discovery Technology, Ningbo University Ningbo Zhejiang 315211 P. R. China .,Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University Ningbo Zhejiang 315211 P. R. China
| | - Feng Ni
- Institute of Drug Discovery Technology, Ningbo University Ningbo Zhejiang 315211 P. R. China .,Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University Ningbo Zhejiang 315211 P. R. China
| |
Collapse
|
7
|
Passow KT, Caldwell HS, Ngo KA, Arnold JJ, Antczak NM, Narayanan A, Jose J, Sturla SJ, Cameron CE, Ciota AT, Harki DA. A Chemical Strategy for Intracellular Arming of an Endogenous Broad-Spectrum Antiviral Nucleotide. J Med Chem 2021; 64:15429-15439. [PMID: 34661397 DOI: 10.1021/acs.jmedchem.1c01481] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The naturally occurring nucleotide 3'-deoxy-3',4'-didehydro-cytidine-5'-triphosphate (ddhCTP) was recently found to exert potent and broad-spectrum antiviral activity. However, nucleoside 5'-triphosphates in general are not cell-permeable, which precludes the direct use of ddhCTP as a therapeutic. To harness the therapeutic potential of this endogenous antiviral nucleotide, we synthesized phosphoramidate prodrug HLB-0532247 (1) and found it to result in dramatically elevated levels of ddhCTP in cells. We compared 1 and 3'-deoxy-3',4'-didehydro-cytidine (ddhC) and found that 1 more effectively reduces titers of Zika and West Nile viruses in cell culture with minimal nonspecific toxicity to host cells. We conclude that 1 is a promising antiviral agent based on a novel strategy of facilitating elevated levels of the endogenous ddhCTP antiviral nucleotide.
Collapse
Affiliation(s)
- Kellan T Passow
- Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States
| | - Haley S Caldwell
- Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York 12144, United States.,The Arbovirus Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, New York 12201, United States
| | - Kiet A Ngo
- The Arbovirus Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, New York 12201, United States
| | - Jamie J Arnold
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, United States
| | - Nicole M Antczak
- Department of Health Sciences and Technology, ETH Zürich, Zürich 8092, Switzerland
| | - Anoop Narayanan
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, United States
| | - Joyce Jose
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.,Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, United States
| | - Shana J Sturla
- Department of Health Sciences and Technology, ETH Zürich, Zürich 8092, Switzerland
| | - Craig E Cameron
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, United States
| | - Alexander T Ciota
- Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York 12144, United States.,The Arbovirus Laboratory, Wadsworth Center, New York State Department of Health, Slingerlands, New York 12201, United States
| | - Daniel A Harki
- Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States
| |
Collapse
|
8
|
Slusarczyk M, Serpi M, Ghazaly E, Kariuki BM, McGuigan C, Pepper C. Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells In Vitro. J Med Chem 2021; 64:8179-8193. [PMID: 34085825 DOI: 10.1021/acs.jmedchem.0c02194] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
A 3'-protected route toward the synthesis of the diastereomers of clinically active ProTides, NUC-1031 and NUC-3373, is described. The in vitro cytotoxic activities of the individual diastereomers were found to be similar to their diastereomeric mixtures. In the KG1a cell line, NUC-1031 and NUC-3373 have preferential cytotoxic effects on leukemic stem cells (LSCs). These effects were not diastereomer-specific and were not observed with the parental nucleoside analogues gemcitabine and FUDR, respectively. In addition, NUC-1031 preferentially targeted LSCs in primary AML samples and cancer stem cells in the prostate cancer cell line, LNCaP. Although the mechanism for this remains incompletely resolved, NUC-1031-treated cells showed increased levels of triphosphate in both LSC and bulk tumor fractions. As ProTides are not dependent on nucleoside transporters, it seems possible that the LSC targeting observed with ProTides may be caused, at least in part, by preferential accumulation of metabolized nucleos(t)ide analogues.
Collapse
Affiliation(s)
- Magdalena Slusarczyk
- Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Redwood Building, Cardiff CF10 3NB, U.K
| | - Michaela Serpi
- Cardiff University, School of Chemistry, Main Building, Park Place, Cardiff CF10 3AT, U.K
| | - Essam Ghazaly
- Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, U.K
| | - Benson M Kariuki
- Cardiff University, School of Chemistry, Main Building, Park Place, Cardiff CF10 3AT, U.K
| | - Christopher McGuigan
- Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Redwood Building, Cardiff CF10 3NB, U.K
| | - Chris Pepper
- Brighton and Sussex Medical School, University of Sussex, Medical Teaching Building, Brighton BN1 9PX, U.K
| |
Collapse
|
9
|
Serpi M, Pertusati F. An overview of ProTide technology and its implications to drug discovery. Expert Opin Drug Discov 2021; 16:1149-1161. [PMID: 33985395 DOI: 10.1080/17460441.2021.1922385] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Introduction: The ProTide technology is a phosphate (or phosphonate) prodrug method devised to deliver nucleoside monophosphate (or monophosphonate) intracellularly bypassing the key challenges of antiviral and anticancer nucleoside analogs. Three new antiviral drugs, exploiting this technology, have been approved by the FDA while others are in clinical studies as anticancer agents.Areas covered: The authors describe the origin and development of this technology and its incredible success in transforming the drug discovery of antiviral and anticancer nucleoside analogues. As evidence, discussion on the antiviral ProTides on the market, and those currently in clinical development are included. The authors focus on how the proven capacity of this technology to generate new drug candidates has stimulated its application to non-nucleoside-based molecules.Expert opinion: The ProTide approach has been extremely successful in delivering blockbuster antiviral medicines and it seems highly promising in oncology. Its application to non-nucleoside-based small molecules is recently emerging and proving effective in other therapeutic areas. However, investigations to explain the lack of activity of certain ProTide series and comprehensive structure activity relationship studies to identify the appropriate phosphoramidate motifs depending on the parent molecule are in our opinion mandatory for the future development of these compounds.
Collapse
Affiliation(s)
| | - Fabrizio Pertusati
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK
| |
Collapse
|
10
|
Liu Z, Klapars A, Simmons B, Bellomo A, Kalinin A, Weisel M, Hill J, Silverman SM. Development and Implementation of an Aluminum-Promoted Phosphorylation in the Uprifosbuvir Manufacturing Route. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00487] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Zhuqing Liu
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Artis Klapars
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Bryon Simmons
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Ana Bellomo
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Alexei Kalinin
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Mark Weisel
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Jerry Hill
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Steven M. Silverman
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| |
Collapse
|
11
|
Yoshida Y, Honma M, Kimura Y, Abe H. Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV-1 Reverse Transcriptase Inhibitors (NRTIs). ChemMedChem 2021; 16:743-766. [PMID: 33230979 DOI: 10.1002/cmdc.202000695] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2020] [Revised: 10/31/2020] [Indexed: 12/13/2022]
Abstract
Acquired immunodeficiency syndrome (AIDS) is caused by infection with the human immunodeficiency virus (HIV). Although treatments against HIV infection are available, AIDS remains a serious disease that causes many deaths annually. Although a variety of anti-HIV drugs have been synthesized and marketed to treat HIV-infected patients, nucleoside analogue reverse transcriptase inhibitors (NRTIs), which mimic nucleosides, are used extensively and remain a subject of interest to medicinal chemists. However, HIV has acquired drug resistance against NRTIs, and thus the struggle to find novel therapies continues. In this review, we trace the trajectory of NRTIs, focusing on the synthesis, mechanisms of action and applications of NRTIs that have been developed.
Collapse
Affiliation(s)
- Yuki Yoshida
- Graduate School of Science, Department of Chemistry, Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan
| | - Masakazu Honma
- Nucleic Acid Medicine Research Laboratories, Research Functions Unit, R&D Division, Kyowa Kirin Co., Ltd., 3-6-6, Asahi-machi, Machida-shi, >, Tokyo, 194-8533, Japan
| | - Yasuaki Kimura
- Graduate School of Science, Department of Chemistry, Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan
| | - Hiroshi Abe
- Graduate School of Science, Department of Chemistry, Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan.,Research Center for Materials Science, Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan.,CREST, Japan Science and Technology Agency, 7, Gobancho, Chiyoda-ku, Tokyo, 102-0076, Japan.,Institute for Glyco-core Research (iGCORE), Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan
| |
Collapse
|
12
|
Miao H, Chen X, Luan Y. Small Molecular Gemcitabine Prodrugs for Cancer Therapy. Curr Med Chem 2020; 27:5562-5582. [PMID: 31419928 DOI: 10.2174/0929867326666190816230650] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2019] [Revised: 05/22/2019] [Accepted: 07/09/2019] [Indexed: 02/04/2023]
Abstract
Gemcitabine as a pyrimidine nucleoside analog anticancer drug has high efficacy for a broad spectrum of solid tumors. Gemcitabine is activated within tumor cells by sequential phosphorylation carried out by deoxycytidine kinase to mono-, di-, and triphosphate nucleotides with the last one as the active form. But the instability, drug resistance and toxicity severely limited its utilization in clinics. In the field of medicinal chemistry, prodrugs have proven to be a very effective means for elevating drug stability and decrease undesirable side effects including the nucleoside anticancer drug such as gemcitabine. Many works have been accomplished in design and synthesis of gemcitabine prodrugs, majority of which were summarized in this review.
Collapse
Affiliation(s)
- He Miao
- Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Shandong Province, Qingdao, China
| | - Xuehong Chen
- Department of Pharmacology, College of Basic Medicine, Qingdao University, Shandong Province, Qingdao, China
| | - Yepeng Luan
- Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Shandong Province, Qingdao, China
| |
Collapse
|
13
|
Dentmon ZW, Kaiser TM, Liotta DC. Synthesis and Antiviral Activity of a Series of 2'- C-Methyl-4'-thionucleoside Monophosphate Prodrugs. Molecules 2020; 25:E5165. [PMID: 33171951 PMCID: PMC7664256 DOI: 10.3390/molecules25215165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 10/29/2020] [Accepted: 10/29/2020] [Indexed: 02/07/2023] Open
Abstract
The NS5B RNA-dependent RNA polymerase of the hepatitis C virus (HCV) is a validated target for nucleoside antiviral drug therapy. We endeavored to synthesize and test a series of 4'-thionucleosides with a monophosphate prodrug moiety for their antiviral activity against HCV and other related viruses in the Flaviviridae family. Nucleoside analogs were prepared via the stereoselective Vorbrüggen glycosylation of various nucleobases with per-acetylated 2-C-methyl-4-thio-d-ribose built in a 10-step synthetic sequence from the corresponding ribonolactone. Conjugation of the thionucleoside to a ProTide phosphoramidate allowed for evaluation of the prodrugs in the cellular HCV replicon assay with anti-HCV activities ranging from single-digit micromolar (μM) to >200 μM. The diminished anti-HCV potency of our best compound compared to its 4'-oxo congener is the subject of ongoing research in our lab and is proposed to stem from changes in sugar geometry imparted by the larger sulfur atom.
Collapse
Affiliation(s)
- Zackery W. Dentmon
- Department of Chemistry, Emory University, 1521 Dickey Dr., Atlanta, GA 30322, USA;
| | | | - Dennis C. Liotta
- Department of Chemistry, Emory University, 1521 Dickey Dr., Atlanta, GA 30322, USA;
| |
Collapse
|
14
|
Arribat M, Cavelier F, Rémond E. Phosphorus-containing amino acids with a P–C bond in the side chain or a P–O, P–S or P–N bond: from synthesis to applications. RSC Adv 2020. [DOI: 10.1039/c9ra10917j] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Strategies for the preparation of phosphorus-containing amino acids and their utility in the organic chemistry, physico-chemistry, agrochemistry, and pharmacology fields are reported.
Collapse
Affiliation(s)
| | - Florine Cavelier
- Institut des Biomolécules Max Mousseron
- IBMM
- UMR 5247
- CNRS
- Université de Montpellier
| | - Emmanuelle Rémond
- Institut des Biomolécules Max Mousseron
- IBMM
- UMR 5247
- CNRS
- Université de Montpellier
| |
Collapse
|
15
|
Tan C, Liu X, Jia H, Zhao X, Chen J, Wang Z, Tan J. Practical Synthesis of Phosphinic Amides/Phosphoramidates through Catalytic Oxidative Coupling of Amines and P(O)-H Compounds. Chemistry 2019; 26:881-887. [PMID: 31625634 DOI: 10.1002/chem.201904237] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2019] [Revised: 10/17/2019] [Indexed: 12/24/2022]
Abstract
Herein, we report a highly efficient ZnI2 -triggered oxidative cross-coupling reaction of P(O)-H compounds and amines. This operationally simple protocol provides unprecedented generic access to phosphinic amides/phosphoramidate derivatives in good yields and short reaction time. Besides, the reaction proceeds under mild conditions, which avoids the use of hazardous reagents, and is applicable to scale-up syntheses as well as late-stage functionalization of drug molecules. The stereospecific coupling is also achieved from readily available optically enriched P(O)-H compounds.
Collapse
Affiliation(s)
- Chen Tan
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Xinyuan Liu
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Huanxin Jia
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Xiaowen Zhao
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Jian Chen
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Zhiyong Wang
- Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Soft Matter Chemistry &, Center for Excellence in Molecular Synthesis of, the Chinese Academy of Sciences, University of Science and Technology of China Institution, Hefei, 230026, P. R. China
| | - Jiajing Tan
- Department of Organic Chemistry, Beijing Advanced Innovation Center for, Soft Matter Science and Engineering, College of Science, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| |
Collapse
|
16
|
Xiang DF, Bigley AN, Desormeaux E, Narindoshvili T, Raushel FM. Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs. Biochemistry 2019; 58:3204-3211. [PMID: 31268686 PMCID: PMC6822272 DOI: 10.1021/acs.biochem.9b00530] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Nucleoside analogues are among the most common medications given for the treatment of viral infections and cancers. The therapeutic effectiveness of nucleoside analogues can be dramatically improved by phosphorylation. The ProTide approach was developed using a phosphorylated nucleoside that is masked by esterification with an amino acid and phenol forming a chiral phosphorus center. The biological activity of the ProTides depends, in part, on the stereochemistry at phosphorus, and thus, it is imperative that efficient methods be developed for the chemical synthesis and isolation of diastereomerically pure ProTides. Chiral ProTides are often synthesized by direct displacement of a labile phenol (p-nitrophenol or pentafluorophenol) from a chiral phosphoramidate precursor with the appropriate nucleoside analogue. The ability to produce these chiral products is dictated by the synthesis of the chiral phosphoramidate precursors. The enzyme phosphotriesterase (PTE) from Pseudomonas diminuta is well-known for its high stereoselectivity and broad substrate profile. Screening PTE variants from enzyme evolution libraries enabled the identification of variants of PTE that can stereoselectively hydrolyze the chiral phosphoramidate precursors. The variant G60A-PTE exhibits a 165-fold preference for hydrolysis of the RP isomer, while the variant In1W-PTE has a 1400-fold preference for hydrolysis of the SP isomer. Using these mutants of PTE, the SP and RP isomers were isolated on a preparative scale with no detectable contamination of the opposite isomer. Combining the simplicity of the enzymatic resolution of the precursor with the latest synthetic strategy will facilitate the production of diastereometrically pure nucleotide phosphoramidate prodrugs.
Collapse
Affiliation(s)
- Dao Feng Xiang
- Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States
| | - Andrew N Bigley
- Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States
| | - Emily Desormeaux
- Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States
| | - Tamari Narindoshvili
- Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States
| | - Frank M Raushel
- Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States
| |
Collapse
|
17
|
Bordoni C, Cima CM, Azzali E, Costantino G, Brancale A. Microwave-assisted organic synthesis of nucleoside ProTide analogues. RSC Adv 2019; 9:20113-20117. [PMID: 35514718 PMCID: PMC9065484 DOI: 10.1039/c9ra01754b] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Accepted: 06/19/2019] [Indexed: 11/21/2022] Open
Abstract
A microwave enhanced synthesis of prodrug nucleotide (ProTide) analogues is presented.
Collapse
Affiliation(s)
| | | | - Elisa Azzali
- P4T Group
- Dipartimento di Farmacia
- University of Parma
- Parma
- Italy
| | | | | |
Collapse
|
18
|
Dimakos V, Taylor MS. Site-Selective Functionalization of Hydroxyl Groups in Carbohydrate Derivatives. Chem Rev 2018; 118:11457-11517. [DOI: 10.1021/acs.chemrev.8b00442] [Citation(s) in RCA: 148] [Impact Index Per Article: 24.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Victoria Dimakos
- Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada
| | - Mark S. Taylor
- Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada
| |
Collapse
|
19
|
Slusarczyk M, Ferrari V, Serpi M, Gönczy B, Balzarini J, McGuigan C. Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5′‐Monophosphate Forms of Anticancer Nucleoside Analogues. ChemMedChem 2018; 13:2305-2316. [DOI: 10.1002/cmdc.201800504] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2018] [Indexed: 11/05/2022]
Affiliation(s)
- Magdalena Slusarczyk
- School of Pharmacy and Pharmaceutical SciencesCardiff University King Edward VII Avenue Cardiff CF10 3NB UK
| | - Valentina Ferrari
- School of Pharmacy and Pharmaceutical SciencesCardiff University King Edward VII Avenue Cardiff CF10 3NB UK
| | - Michaela Serpi
- School of Pharmacy and Pharmaceutical SciencesCardiff University King Edward VII Avenue Cardiff CF10 3NB UK
| | - Blanka Gönczy
- School of Pharmacy and Pharmaceutical SciencesCardiff University King Edward VII Avenue Cardiff CF10 3NB UK
| | - Jan Balzarini
- Laboratory of Virology and ChemotherapyRega Institute for Medical Research Herestraat 49 3000 Leuven Belgium
| | - Christopher McGuigan
- School of Pharmacy and Pharmaceutical SciencesCardiff University King Edward VII Avenue Cardiff CF10 3NB UK
| |
Collapse
|
20
|
Cini E, Barreca G, Carcone L, Manetti F, Rasparini M, Taddei M. Stereoselective Synthesis of Sofosbuvir through Nucleoside Phosphorylation Controlled by Kinetic Resolution. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800158] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Elena Cini
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| | | | - Luca Carcone
- Chemessentia srl; Via Bovio 2 28100 Novara Italy
| | - Fabrizio Manetti
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| | | | - Maurizio Taddei
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| |
Collapse
|
21
|
Granger E, Solomianko K, Young C, Erb J. Exploration of chiral Lewis acid Mg 2+ catalysts in the synthesis of aryl organophosphate triesters from phosphorus oxychloride through a three-step, two-pot substitution sequence. Tetrahedron Lett 2018. [DOI: 10.1016/j.tetlet.2018.02.066] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
22
|
Slusarczyk M, Serpi M, Pertusati F. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antivir Chem Chemother 2018; 26:2040206618775243. [PMID: 29792071 PMCID: PMC5971382 DOI: 10.1177/2040206618775243] [Citation(s) in RCA: 68] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Accepted: 04/09/2018] [Indexed: 12/15/2022] Open
Abstract
Following the first report on the nucleoside phosphoramidate (ProTide) prodrug approach in 1990 by Chris McGuigan, the extensive investigation of ProTide technology has begun in many laboratories. Designed with aim to overcome limitations and the key resistance mechanisms associated with nucleoside analogues used in the clinic (poor cellular uptake, poor conversion to the 5'-monophosphate form), the ProTide approach has been successfully applied to a vast number of nucleoside analogues with antiviral and anticancer activity. ProTides consist of a 5'-nucleoside monophosphate in which the two hydroxyl groups are masked with an amino acid ester and an aryloxy component which once in the cell is enzymatically metabolized to deliver free 5'-monophosphate, which is further transformed to the active 5'-triphosphate form of the nucleoside analogue. In this review, the seminal contribution of Chris McGuigan's research to this field is presented. His technology proved to be extremely successful in drug discovery and has led to two Food and Drug Administration-approved antiviral agents.
Collapse
Affiliation(s)
| | - Michaela Serpi
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK
| | - Fabrizio Pertusati
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK
| |
Collapse
|
23
|
Abstract
The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of nucleoside analogue monophosphates and monophosphonates. In this approach, the hydroxyls of the monophosphate or monophosphonate groups are masked by an aromatic group and an amino acid ester moiety, which are enzymatically cleaved-off inside cells to release the free nucleoside monophosphate and monophosphonate species. Structurally, this represents the current end-point of an extensive medicinal chemistry endeavor that spans almost three decades. It started from the masking of nucleoside monophosphate and monophosphonate groups by simple alkyl groups and evolved into the sophisticated ProTide system as known today. This technology has been extensively employed in drug discovery, and it has already led to the discovery of two FDA-approved (antiviral) ProTides. In this work, we will review the development of the ProTide technology, its application in drug discovery, and its role in the improvement of drug delivery and efficacy.
Collapse
Affiliation(s)
- Youcef Mehellou
- School of Pharmacy and Pharmaceutical Sciences , Cardiff University , Redwood Building , Cardiff CF10 3NB , U.K
| | - Hardeep S Rattan
- School of Pharmacy, College of Medical and Dental Sciences , University of Birmingham , Edgbaston , Birmingham B15 2TT , U.K
| | - Jan Balzarini
- Laboratory of Virology and Chemotherapy , Rega Institute for Medical Research , Herestraat 49 , 3000 Leuven , Belgium
| |
Collapse
|